Latest On ESSA Pharma Inc (EPIX):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-09 12:38 EST | News | ESSA Pharma GAAP EPS of -$0.16 beats by $0.04 | N/A |  |
| 2023-02-07 18:44 EST | News | ESSA Pharma GAAP EPS of -$0.15 | N/A | |
| 2023-02-06 17:19 EST | News | ESSA Pharma: One Asset, One Program Company With Little Data | N/A | |
| 2022-12-13 22:56 EST | News | ESSA Pharma GAAP EPS of -$0.14 | N/A | |
| 2022-11-16 11:07 EST | News | ESSA Pharma: EPI-7386+Xtandi Combination Has Shown Highest Efficacy In Metastatic, Castration-Resistant Prostate Cancer | N/A | |
| 2022-10-31 17:28 EST | News | ESSA drops 26% as Johnson & Johnson ends trial enrollment for lead asset | N/A | |
| 2022-10-26 16:20 EST | News | ESSA Pharma jumps 91% on Phase 1/2 data for prostate cancer therapy | N/A | |
| 2022-08-26 04:03 EST | News | ESSA Pharma Inc.: Selling For Under Cash Value | N/A | |
| 2022-08-04 10:30 EST | News | ESSA Pharma GAAP EPS of -$0.20 | N/A | |
| 2022-05-11 03:06 EST | News | ESSA Pharma GAAP EPS of -$0.25 | N/A | |
| 2022-04-14 22:07 EST | News | ESSA Pharma (EPIX) Presents At Oppenheimer Healthcare Conference | N/A | |
| 2022-02-03 10:47 EST | News | ESSA Pharma GAAP EPS of -$0.21 | N/A | |
| 2022-01-19 11:50 EST | News | ESSA Pharma begins dosing of EPI-7386 in phase 1/2 prostate cancer study | N/A | |
| 2021-11-18 14:13 EST | News | ESSA Pharma EPS beats by $0.03 | N/A | |
| 2021-11-11 05:15 EST | News | ESSA Pharma: Why I Remain Bullish | N/A | |
| 2021-10-15 13:45 EST | News | Warning: EPIX is at high risk of performing badly | N/A | |
| 2021-10-08 06:58 EST | News | ESSA Pharma rises ~5% amid preclinical data show for potential prostate cancer drug | N/A | |
| 2021-10-07 09:41 EST | News | EPIX is at high risk of performing badly | N/A | |
| 2021-10-07 09:31 EST | News | ESSA Pharma collaborates with Caris Life Sciences for liquid biopsy profiling | N/A | |
| 2021-09-27 16:55 EST | News | Warning: EPIX has been downgraded to Very Bearish | N/A | |
| 2021-09-23 02:07 EST | News | Warning: EPIX has been downgraded to Very Bearish. | N/A | |
| 2021-08-16 17:08 EST | News | ESSA Pharma reports Q3 results | N/A | |
| 2021-08-16 17:08 EST | News | ESSA Pharma at an eight-month low after delaying data read from prostate cancer trial | N/A | |
| 2021-08-10 03:13 EST | News | ESSA Pharma falls to six-month low on above average volume | N/A | |
| 2021-05-06 11:05 EST | News | ESSA Pharma reports Q1 results | N/A | |
| 2021-03-14 14:00 EST | News | ESSA Pharma (ESSA) Investor Presentation - Slideshow | N/A | |
| 2021-02-18 14:04 EST | News | ESSA Pharma prices equity offering at $27 | N/A | |
| 2021-02-17 02:49 EST | News | ESSA Pharma commences public offering of $100M shares | N/A | |
| 2021-02-12 23:41 EST | Financials | Company financials have been released. | Neutral | |
| 2021-02-12 00:22 EST | News | ESSA Pharma reports Q4 results | N/A | |
| 2021-02-12 00:21 EST | News | ESSA is up after early data for EPI-7386 in prostate cancer | N/A | |
| 2021-02-02 07:08 EST | News | ESSA Pharma: Update Including Clinical Collaboration Agreement With Janssen | N/A | |
| 2021-01-13 13:03 EST | News | ESSA Pharma and Janssen to test combo treatments in prostate cancer setting | N/A | |
| 2020-12-17 03:42 EST | Financials | Company financials have been released. | Neutral | |
| 2020-12-16 05:14 EST | News | ESSA Pharma EPS beats by $0.02 | N/A | |
| 2020-11-26 19:53 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 15:44 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-31 14:56 EST | News | ESSA Pharma to delist from from TSX-V | N/A | |
| 2020-09-26 12:40 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 04:47 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-14 08:55 EST | News | ESSA Pharma nabs U.S. accelerated review tag for prostate cancer drug | N/A | |
| 2020-09-01 00:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-20 16:43 EST | News | ESSA's Novel Prostate Cancer Treatment In Clinical Trial: Pfizer Is New Lead Investor | N/A | |
| 2020-08-14 08:42 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-09 00:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-07 17:32 EST | News | ESSA Pharma EPS beats by $0.06 | N/A | |
| 2020-07-31 21:38 EST | News | ESSA Pharma completes $49M aggregate gross proceeds | N/A | |
| 2020-07-31 00:54 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-29 19:32 EST | News | ESSA Pharma prices equity offering at $6/share | N/A | |
| 2020-07-28 20:30 EST | News | ESSA pharma launches equity offering | N/A | |
About ESSA Pharma Inc (EPIX):
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada.
General
- Name ESSA Pharma Inc
- Symbol EPIX
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 25
- Last Split Factor1:20
- Last Split Date2018-04-25
- Fiscal Year EndSeptember
- IPO Date2015-07-09
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.essapharma.com
View More
Valuation
- Price/Book (Most Recent Quarter) 16.91
View More
Financials
- Most Recent Quarter 2020-12-31
- Return on Assets -26%
- Return on Equity -42%
- Earnings Per Share -$1.75
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 1.2 billion
- EBITDA -11033670
- Analyst Target Price $0.75
- Book Value Per Share $2.21
View More
Share Statistics
- Shares Outstanding 39.34 million
- Shares Float 20.9 million
- % Held by Insiders 281%
- % Held by Institutions 64.04%
- Shares Short 62217
- Shares Short Prior Month 62714
- Short Ratio 0.11
View More
Technicals
- Beta 1.78
- 52 Week High $32.65
- 52 Week Low $3.5
- 50 Day Moving Average 25.25
- 200 Day Moving Average 12.6
View More
Dividends
- Dividend Date 2018-04-25
- ExDividend Date N/A
- Dividend Yield 0%
View More
ESSA Pharma Inc (EPIX) Dividend Calendar:
EPIX's last dividend payment was made to shareholders on April 25, 2018.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
ESSA Pharma Inc (EPIX) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-11 | $N/A | -$0.20 | -$0.17 | -20.8% |
| 2020-09-30 | 2020-12-15 | $N/A | -$0.17 | -$0.20 | 15.3% |
| 2020-06-30 | 2020-08-06 | $N/A | -$0.24 | -$0.36 | 33.44% |
| 2020-03-31 | 2020-05-07 | $N/A | -$0.45 | -$0.22 | -105.2% |
| 2019-12-31 | 2020-02-13 | $N/A | -$0.22 | -$0.18 | -22.63% |
| 2019-09-30 | 2019-12-19 | $N/A | -$0.23 | -$0.17 | -32.13% |
| 2019-06-30 | 2019-08-14 | $N/A | -$0.52 | -$0.54 | 4.29% |
| 2019-03-31 | 2019-05-10 | $N/A | -$0.54 | -$0.44 | -23.36% |
| 2018-12-31 | 2019-02-07 | $N/A | -$0.43 | ||
| 2018-09-30 | 2018-12-13 | $N/A | -$0.40 | -$0.43 | 7.29% |
| 2018-06-30 | 2018-08-14 | $N/A | -$0.50 | -$0.74 | 32.34% |
| 2018-03-31 | 2018-05-14 | $N/A | -$0.83 | -$0.40 | -104.75% |
| 2017-12-31 | 2018-02-13 | $N/A | -$1.40 | ||
| 2017-09-30 | 2017-12-12 | $N/A | -$1.40 | -$3.64 | 61.53% |
| 2017-06-30 | 2017-08-15 | $N/A | -$3.16 | -$3.53 | 10.35% |
| 2017-03-31 | 2017-05-15 | $N/A | -$5.21 | -$2.20 | -136.74% |
| 2016-12-31 | 2017-02-13 | $N/A | $0.92 | ||
| 2016-09-30 | 2016-12-14 | $N/A | -$3.15 | ||
| 2016-06-30 | 2016-08-12 | $N/A | -$2.66 | ||
| 2016-03-31 | 2016-05-13 | $N/A | -$0.78 | ||
| 2015-12-31 | 2016-02-12 | $N/A | -$2.30 | -$2.81 | 18.09% |
| 2015-09-30 | 2015-12-14 | $N/A | $0.08 | -$0.07 | 214.29% |
| 2015-06-30 | 2015-08-17 | $N/A | -$0.26 | -$0.13 | -100% |
| 2015-03-31 | 2015-05-28 | $N/A | -$0.20 | -$0.22 | 9.09% |
ESSA Pharma Inc (EPIX) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Apr 30 2020 | Mar 31 2020 |
|---|---|---|---|---|---|
| Research Development | N/A | 2.24 million | N/A | 2.7 million | 4.62 million |
| Income Before Tax | N/A | -4.55 million | N/A | -4.93 million | -9.35 million |
| Selling General Administrative | N/A | 2.17 million | N/A | 2.14 million | 4.84 million |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Ebit | N/A | -4.42 million | N/A | -4.7 million | -9.23 million |
| Operating Income | N/A | -4.42 million | N/A | -4.88 million | -9.49 million |
| Income Tax Expense | -35149 | N/A | N/A | N/A | 4000 |
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A |
| Total Other Income Expense Net | N/A | -89452 | N/A | -28641 | 17173 |
| Net Income From Continuing Operations | N/A | -4.53 million | N/A | -4.93 million | -9.36 million |
| Net Income Applicable to Common Shares | -6.53 million | N/A | -4.93 million | -4.93 million | -9.36 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Apr 30 2020 | Mar 31 2020 | Jan 31 2020 |
|---|---|---|---|---|---|
| Investments | -21.74 million | N/A | N/A | N/A | N/A |
| Change to Liabilities | N/A | -175243 | -175243 | 255034 | 255034 |
| Total Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
| Net Borrowings | N/A | -30287 | -30287 | -29404 | -29404 |
| Total Cash Flow from Financial Activities | 46.05 million | N/A | -142925 | N/A | N/A |
| Change to Operating Activities | N/A | 55910 | 42939 | -484081 | -484081 |
| Change in Cash | 19.84 million | N/A | -3.43 million | N/A | N/A |
| Total Cash from Operating Activities | -4.43 million | -3.29 million | -3.29 million | -5.9 million | -5.9 million |
| Depreciation | 13858 | N/A | 32155 | N/A | N/A |
| Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Financing Activities | N/A | -194268 | -194268 | -84733 | -84733 |
| Change to Net Income | N/A | 1.74 million | 1.74 million | 3.67 million | 3.67 million |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Apr 30 2020 | Mar 31 2020 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | 1.33 million | N/A | N/A | 1.52 million |
| Total Stockholder Equity | N/A | 79.24 million | N/A | N/A | 40.28 million |
| Other Current Liabilities | N/A | N/A | N/A | 36.94 million | N/A |
| Total Assets | N/A | 80.57 million | N/A | N/A | 41.79 million |
| Common Stock | 134.39 million | N/A | 76.77 million | N/A | 76.63 million |
| Other Current Assets | 27581 | 55162 | N/A | 76.77 million | N/A |
| Retained Earnings | -87.5 million | -80.97 million | -73.72 million | -73.72 million | -68.79 million |
| Other Liabilities | 38246 | N/A | N/A | 83750 | 44172 |
| Other Assets | 277637 | N/A | 274085 | 274085 | 274085 |
| Cash | N/A | 56.32 million | N/A | 36.48 million | 39.91 million |
| Total Current Liabilities | 2.04 million | 1.2 million | N/A | 1.27 million | 1.47 million |
| Other Stockholder Equity | -2.08 million | N/A | 33.89 million | 33.89 million | 32.44 million |
| Property, Plant & Equipment | N/A | N/A | 82743 | 82743 | 110324 |
| Total Current Assets | 75.9 million | 80.3 million | N/A | 37.74 million | 41.22 million |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | 74.1 million | N/A | 36.75 million | 36.75 million | 40.09 million |
| Short Term Investments | N/A | 22.01 million | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A |
| Inventory | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | 2.01 million | 1.14 million | N/A | 1.18 million | 1.36 million |
ESSA Pharma Inc (EPIX) Chart:
ESSA Pharma Inc (EPIX) News:
Below you will find a list of latest news for ESSA Pharma Inc (EPIX) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
ESSA Pharma Inc (EPIX) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 2.5 | 3.6 | CALL | 0 | 10 | 744.6 | TRUE | 0 | 0 |
| 2024-05-17 | 5 | 0 | CALL | 0 | 0 | 457.82 | TRUE | 0 | 0 |
| 2024-05-17 | 7.5 | 0.35 | CALL | 1 | 23 | 102.8 | FALSE | 0.35 | 0 |
| 2024-05-17 | 10 | 0.15 | CALL | 0 | 20 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 12.5 | 0.05 | CALL | 0 | 7 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 15 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 17.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 7.5 | 1.5 | PUT | 0 | 33 | 0 | TRUE | 0 | 0 |
| 2024-05-17 | 10 | 0 | PUT | 0 | 0 | 330 | TRUE | 0 | 0 |
| 2024-05-17 | 12.5 | 0 | PUT | 0 | 0 | 419.48 | TRUE | 0 | 0 |
| 2024-05-17 | 15 | 0 | PUT | 0 | 0 | 484.89 | TRUE | 0 | 0 |
| 2024-05-17 | 17.5 | 0 | PUT | 0 | 0 | 509.1 | TRUE | 0 | 0 |
| 2024-06-21 | 2.5 | 0 | CALL | 0 | 0 | 188.21 | TRUE | 0 | 0 |
| 2024-06-21 | 5 | 0 | CALL | 0 | 0 | 243 | TRUE | 0 | 0 |
| 2024-06-21 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 10 | 0.2 | CALL | 0 | 11 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 12.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 15 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 7.5 | 0 | PUT | 0 | 0 | 140.23 | TRUE | 0 | 0 |
| 2024-06-21 | 10 | 0 | PUT | 0 | 0 | 140.71 | TRUE | 0 | 0 |
| 2024-06-21 | 12.5 | 0 | PUT | 0 | 0 | 196.97 | TRUE | 0 | 0 |
| 2024-06-21 | 15 | 0 | PUT | 0 | 0 | 264.52 | TRUE | 0 | 0 |
| 2024-07-19 | 2.5 | 5.4 | CALL | 0 | 6 | 270.47 | TRUE | 0 | 0 |
| 2024-07-19 | 5 | 1.7 | CALL | 0 | 32 | 101.88 | TRUE | 0 | 0 |
| 2024-07-19 | 7.5 | 1 | CALL | 5 | 74 | 93.29 | FALSE | 1 | 0 |
| 2024-07-19 | 10 | 0.2 | CALL | 0 | 40 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 12.5 | 1.46 | CALL | 0 | 157 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 15 | 0.7 | CALL | 0 | 42 | 137.73 | FALSE | 0 | 0 |
| 2024-07-19 | 17.5 | 0.4 | CALL | 0 | 15 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 2.5 | 0.35 | PUT | 0 | 2 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 5 | 0.78 | PUT | 0 | 1 | 126.36 | FALSE | 0 | 0 |
| 2024-07-19 | 7.5 | 2.08 | PUT | 0 | 14 | 113.18 | TRUE | 0 | 0 |
| 2024-07-19 | 10 | 3.19 | PUT | 0 | 0 | 143.42 | TRUE | 0 | 0 |
| 2024-07-19 | 12.5 | 5.15 | PUT | 0 | 6 | 193.12 | TRUE | 0 | 0 |
| 2024-07-19 | 15 | 7.5 | PUT | 0 | 11 | 175.26 | TRUE | 0 | 0 |
| 2024-07-19 | 17.5 | 0 | PUT | 0 | 0 | 230.06 | TRUE | 0 | 0 |
| 2024-10-18 | 2.5 | 0 | CALL | 0 | 0 | 128.45 | TRUE | 0 | 0 |
| 2024-10-18 | 5 | 2.9 | CALL | 0 | 45 | 188.28 | TRUE | 0 | 0 |
| 2024-10-18 | 7.5 | 1.97 | CALL | 0 | 18 | 122.77 | FALSE | 0 | 0 |
| 2024-10-18 | 10 | 1.35 | CALL | 0 | 18 | 0 | FALSE | 0 | 0 |
| 2024-10-18 | 12.5 | 1 | CALL | 0 | 40 | 0 | FALSE | 0 | 0 |
| 2024-10-18 | 15 | 1.86 | CALL | 0 | 2 | 138.07 | FALSE | 0 | 0 |
| 2024-10-18 | 17.5 | 1.54 | CALL | 0 | 46 | 139.11 | FALSE | 0 | 0 |
| 2024-10-18 | 2.5 | 0 | PUT | 0 | 0 | 157.52 | FALSE | 0 | 0 |
| 2024-10-18 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-10-18 | 7.5 | 2.1 | PUT | 0 | 2 | 124.9 | TRUE | 0 | 0 |
| 2024-10-18 | 10 | 3.7 | PUT | 0 | 6 | 133.45 | TRUE | 0 | 0 |
| 2024-10-18 | 12.5 | 0 | PUT | 0 | 0 | 127.79 | TRUE | 0 | 0 |
| 2024-10-18 | 15 | 0 | PUT | 0 | 0 | 137.18 | TRUE | 0 | 0 |
| 2024-10-18 | 17.5 | 0 | PUT | 0 | 0 | 182.38 | TRUE | 0 | 0 |
Latest EPIX Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:57 PM EST | 25 | $4.35 |
| Jun 13, 2022 7:58 PM EST | 100 | $4.405 |
| Jun 13, 2022 7:58 PM EST | 5 | $4.39 |
| Jun 13, 2022 7:59 PM EST | 100 | $4.41 |
| Jun 13, 2022 7:59 PM EST | 5 | $4.39 |
ESSA Pharma Inc (EPIX) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-30 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1633932/000110465920078083/0001104659-20-078083-index.htm |
| 2018-01-30 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1633932/000000000018003384/0000000000-18-003384-index.htm |
| 2018-07-05 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1633932/000000000018020699/0000000000-18-020699-index.htm |
| 2019-10-17 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1633932/000000000019014646/0000000000-19-014646-index.htm |
| 2020-08-06 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1633932/000007800320000062/0000078003-20-000062-index.htm |
| 2020-10-01 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1633932/000089924320026708/0000899243-20-026708-index.htm |
| 2018-10-17 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1633932/000092189518002790/0000921895-18-002790-index.htm |
| 2019-06-28 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1633932/000092189519001918/0000921895-19-001918-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1633932/000092189520000523/0000921895-20-000523-index.htm |
| 2019-08-28 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1633932/000092963819000785/0000929638-19-000785-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1633932/000092963820000238/0000929638-20-000238-index.htm |
| 2020-08-03 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1633932/000092963820000796/0000929638-20-000796-index.htm |
| 2019-11-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1633932/000094787119000801/0000947871-19-000801-index.htm |
| 2020-08-19 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1633932/000094787120000697/0000947871-20-000697-index.htm |
| 2019-08-30 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1633932/000095017219000105/0000950172-19-000105-index.htm |
| 2019-11-01 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1633932/000110465919058826/0001104659-19-058826-index.htm |
| 2019-11-05 | F-3/A | Registration statement by foreign private issuers | https://www.sec.gov/Archives/edgar/data/1633932/000110465919059949/0001104659-19-059949-index.htm |
| 2019-12-20 | 20-F | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1633932/000110465919074530/0001104659-19-074530-index.htm |
| 2020-04-13 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1633932/000110465920045976/0001104659-20-045976-index.htm |
| 2020-04-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000110465920046029/0001104659-20-046029-index.htm |
| 2020-04-15 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000110465920046990/0001104659-20-046990-index.htm |
| 2020-06-30 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1633932/000110465920078083/0001104659-20-078083-index.htm |
| 2020-07-28 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1633932/000110465920087327/0001104659-20-087327-index.htm |
| 2020-07-30 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1633932/000110465920088000/0001104659-20-088000-index.htm |
| 2020-08-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000110465920091290/0001104659-20-091290-index.htm |
| 2020-08-13 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1633932/000110465920094164/0001104659-20-094164-index.htm |
| 2019-10-09 | F-3 | Registration statement by foreign private issuers | https://www.sec.gov/Archives/edgar/data/1633932/000114420419047713/0001144204-19-047713-index.htm |
| 2018-01-31 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1633932/000119312518027466/0001193125-18-027466-index.htm |
| 2018-02-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1633932/000119312518037709/0001193125-18-037709-index.htm |
| 2018-05-18 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1633932/000119312518168189/0001193125-18-168189-index.htm |
| 2018-05-18 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1633932/000119312518168196/0001193125-18-168196-index.htm |
| 2018-06-19 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1633932/000119312518196616/0001193125-18-196616-index.htm |
| 2019-01-11 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1633932/000119312519006217/0001193125-19-006217-index.htm |
| 2019-02-13 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1633932/000119312519037826/0001193125-19-037826-index.htm |
| 2019-09-06 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1633932/000119312519240118/0001193125-19-240118-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1633932/000119312520037345/0001193125-20-037345-index.htm |
| 2018-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1633932/000119380518000213/0001193805-18-000213-index.htm |
| 2020-10-01 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1633932/000120919120052722/0001209191-20-052722-index.htm |
| 2020-10-01 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1633932/000120919120052723/0001209191-20-052723-index.htm |
| 2020-10-01 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1633932/000120919120052724/0001209191-20-052724-index.htm |
| 2020-10-01 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1633932/000120919120052725/0001209191-20-052725-index.htm |
| 2020-10-01 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1633932/000120919120052726/0001209191-20-052726-index.htm |
| 2020-10-01 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1633932/000120919120052727/0001209191-20-052727-index.htm |
| 2020-10-01 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1633932/000120919120052729/0001209191-20-052729-index.htm |
| 2020-10-01 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1633932/000120919120052730/0001209191-20-052730-index.htm |
| 2020-10-01 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1633932/000120919120052748/0001209191-20-052748-index.htm |
| 2020-10-01 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1633932/000120919120052750/0001209191-20-052750-index.htm |
| 2020-10-02 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1633932/000120919120053375/0001209191-20-053375-index.htm |
| 2020-10-02 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1633932/000120919120053376/0001209191-20-053376-index.htm |
| 2020-11-06 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1633932/000121390020035602/0001213900-20-035602-index.htm |
| 2018-02-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956918000243/0001279569-18-000243-index.htm |
| 2018-02-23 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956918000321/0001279569-18-000321-index.htm |
| 2018-03-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956918000386/0001279569-18-000386-index.htm |
| 2018-03-29 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956918000602/0001279569-18-000602-index.htm |
| 2018-04-20 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956918000783/0001279569-18-000783-index.htm |
| 2018-04-24 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956918000796/0001279569-18-000796-index.htm |
| 2018-04-25 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956918000806/0001279569-18-000806-index.htm |
| 2018-04-26 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956918000819/0001279569-18-000819-index.htm |
| 2018-05-08 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956918000962/0001279569-18-000962-index.htm |
| 2018-05-11 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956918001032/0001279569-18-001032-index.htm |
| 2018-05-15 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956918001059/0001279569-18-001059-index.htm |
| 2018-05-25 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956918001166/0001279569-18-001166-index.htm |
| 2018-06-28 | F-3 | Registration statement by foreign private issuers | https://www.sec.gov/Archives/edgar/data/1633932/000127956918001382/0001279569-18-001382-index.htm |
| 2018-07-12 | F-3/A | Registration statement by foreign private issuers | https://www.sec.gov/Archives/edgar/data/1633932/000127956918001468/0001279569-18-001468-index.htm |
| 2018-07-12 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1633932/000127956918001470/0001279569-18-001470-index.htm |
| 2018-08-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956918001704/0001279569-18-001704-index.htm |
| 2018-08-29 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956918001774/0001279569-18-001774-index.htm |
| 2018-10-22 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956918002070/0001279569-18-002070-index.htm |
| 2018-11-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956918002207/0001279569-18-002207-index.htm |
| 2018-12-13 | 20-F | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1633932/000127956918002468/0001279569-18-002468-index.htm |
| 2018-12-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956918002470/0001279569-18-002470-index.htm |
| 2019-02-07 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956919000240/0001279569-19-000240-index.htm |
| 2019-02-11 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956919000258/0001279569-19-000258-index.htm |
| 2019-02-19 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956919000337/0001279569-19-000337-index.htm |
| 2019-03-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956919000578/0001279569-19-000578-index.htm |
| 2019-03-18 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956919000610/0001279569-19-000610-index.htm |
| 2019-03-28 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956919000750/0001279569-19-000750-index.htm |
| 2019-03-28 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956919000751/0001279569-19-000751-index.htm |
| 2019-04-12 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956919000885/0001279569-19-000885-index.htm |
| 2019-04-17 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956919000925/0001279569-19-000925-index.htm |
| 2019-04-25 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956919000970/0001279569-19-000970-index.htm |
| 2019-05-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956919001052/0001279569-19-001052-index.htm |
| 2019-05-10 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956919001142/0001279569-19-001142-index.htm |
| 2019-05-16 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956919001201/0001279569-19-001201-index.htm |
| 2019-05-28 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956919001264/0001279569-19-001264-index.htm |
| 2019-06-24 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956919001415/0001279569-19-001415-index.htm |
| 2019-06-26 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956919001434/0001279569-19-001434-index.htm |
| 2019-06-27 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956919001441/0001279569-19-001441-index.htm |
| 2019-07-08 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956919001488/0001279569-19-001488-index.htm |
| 2019-07-15 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956919001524/0001279569-19-001524-index.htm |
| 2019-07-30 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956919001607/0001279569-19-001607-index.htm |
| 2019-07-31 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956919001617/0001279569-19-001617-index.htm |
| 2019-08-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956919001769/0001279569-19-001769-index.htm |
| 2019-08-23 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956919001822/0001279569-19-001822-index.htm |
| 2019-08-28 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956919001838/0001279569-19-001838-index.htm |
| 2019-09-05 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956919001871/0001279569-19-001871-index.htm |
| 2019-09-19 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956919001956/0001279569-19-001956-index.htm |
| 2019-09-30 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956919002001/0001279569-19-002001-index.htm |
| 2019-10-07 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956919002063/0001279569-19-002063-index.htm |
| 2019-10-18 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956919002139/0001279569-19-002139-index.htm |
| 2019-10-21 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956919002147/0001279569-19-002147-index.htm |
| 2019-10-28 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956919002177/0001279569-19-002177-index.htm |
| 2019-10-30 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956919002192/0001279569-19-002192-index.htm |
| 2019-12-20 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956919002524/0001279569-19-002524-index.htm |
| 2020-02-11 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956920000155/0001279569-20-000155-index.htm |
| 2020-02-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956920000172/0001279569-20-000172-index.htm |
| 2020-02-28 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956920000227/0001279569-20-000227-index.htm |
| 2020-03-31 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956920000448/0001279569-20-000448-index.htm |
| 2020-04-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956920000514/0001279569-20-000514-index.htm |
| 2020-05-01 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956920000642/0001279569-20-000642-index.htm |
| 2020-05-07 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956920000703/0001279569-20-000703-index.htm |
| 2020-05-15 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956920000787/0001279569-20-000787-index.htm |
| 2020-05-27 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956920000840/0001279569-20-000840-index.htm |
| 2020-06-22 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956920000962/0001279569-20-000962-index.htm |
| 2020-07-15 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956920001061/0001279569-20-001061-index.htm |
| 2020-07-28 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956920001105/0001279569-20-001105-index.htm |
| 2020-07-29 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956920001109/0001279569-20-001109-index.htm |
| 2020-07-31 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956920001131/0001279569-20-001131-index.htm |
| 2020-08-07 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956920001172/0001279569-20-001172-index.htm |
| 2020-09-10 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956920001290/0001279569-20-001290-index.htm |
| 2020-09-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956920001299/0001279569-20-001299-index.htm |
| 2020-09-17 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956920001330/0001279569-20-001330-index.htm |
| 2020-09-21 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1633932/000127956920001340/0001279569-20-001340-index.htm |
| 2018-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1633932/000153526418000014/0001535264-18-000014-index.htm |
| 2020-10-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1633932/000156459020047744/0001564590-20-047744-index.htm |
| 2018-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1633932/000158064218000855/0001580642-18-000855-index.htm |
| 2018-03-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1633932/000158064218001488/0001580642-18-001488-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1633932/000158064219000774/0001580642-19-000774-index.htm |
| 2019-05-23 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1633932/000158064219002593/0001580642-19-002593-index.htm |
| 2019-07-15 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1633932/000158064219003213/0001580642-19-003213-index.htm |
| 2019-08-30 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1633932/000158064219004061/0001580642-19-004061-index.htm |
| 2020-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1633932/000158064220000511/0001580642-20-000511-index.htm |
| 2018-02-02 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1633932/999999999518000329/9999999995-18-000329-index.htm |
| 2018-07-17 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1633932/999999999518001814/9999999995-18-001814-index.htm |
| 2019-11-05 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1633932/999999999519002482/9999999995-19-002482-index.htm |